IFNA1 and Alzheimer disease: Intriguingly, polymorphisms of ISGs, including OAS1, ITGAM, LAPTM5, and LILRB4, were conjointly identified as a significant risk factor for AD, implicating IFN pathway as a genetic modifier (Salih et al., 2019).